AMA Releases Additional CPT for Johnson & Johnson COVID Vaccine

The American Medical Association (AMA) released on January 19th, 2021 new CPT codes for the COVID vaccine administration and the vaccine by Johnson and Johnson, which is still pending approval by the FDA.  This COVID-19 vaccine was under development by Janssen Pharmaceutica, a division of Johnson & Johnson.

The new CPT codes are:

  • 91303    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5×1010 viral particles/0.5mL dosage, for intramuscular use
  • 0031A    Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5×1010 viral particles/0.5mL dosage, single dose

Go to the following link to read more: AMA announces update to COVID-19 vaccine CPT codes | American Medical Association (ama-assn.org)

Documentation and coding accuracy is always essential for ALL patient encounters.

Subscribe to our MRA Newsletter

Bringing peace of mind to healthcare since 1986

Share this post with your friends

You may be interested in...

AHIMA Approved

This program has been approved for continuing education unit(s) (CEUs) for use in fulfilling the continuing education requirements of the American Health Information Management Association (AHIMA). Granting of Approved CEUs from AHIMA does not constitute endorsement of the program content or its program provider.